NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Germitec

Germitec

Private
BordeauxHealthcare & Life Scienceshttps://www.germitec.com

Last Round

Series B

Feb 12, 2025

Total Funding Raised

$68.6M

Company Overview

Germitec is a medical devices company that provides UV-C technology for High-Level Disinfection (HLD) of ultrasound probes.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Non-AI

Keywords

high-level disinfectionHLDUV-C disinfectionultrasound probe disinfectioninfection controlprobe reprocessingchemical-free disinfectionautomated disinfectionUV sterilizermedical devicehealthcare-associated infectionsHAIsdigital traceabilityMedTechTEE probes

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Germitec Comparables

Compare Germitec with similar companies based on industry and business-model similarity.

Germitec comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Germitec Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BFeb 12, 2025
DebtNov 14, 2023
Series AMay 10, 2022

Key People

Founding team and executive leadership

Jose Da Gloria

Deputy Chief Executive Officer

Executive Team

Germitec Investors

Notable investors and investment history

Germitec investors
InvestorRounds
European Investment Bank GroupDebt
Aquiti GestionSeries A
Galia GestionSeries A
EurazeoSeries B
Kurma PartnersSeries B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 4, 2025

    Commercial launch of Chronos Max announced.

  • Jun 3, 2025

    Will attend the APIC 2025 Annual Conference.

Germitec Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Germitec Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Germitec's valuation, stock price, and market status.

Firmographic Details

HeadquartersBordeaux
Employee Range66
Year Founded2005
Last FundingFeb 12, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.